Dapsone and Pharyngitis - a phase IV clinical study of FDA data

Summary:

Pharyngitis is reported as a side effect among people who take Dapsone (dapsone), especially for people who are female, 30-39 old, also take Hydroxyzine Hydrochloride, and have Asthma.

The phase IV clinical study analyzes which people have Pharyngitis when taking Dapsone. It is created by eHealthMe based on reports of 11,499 people who have side effects when taking Dapsone from the FDA, and is updated regularly.

What is Dapsone?

Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.

What is Pharyngitis?

Pharyngitis (inflammation of the pharynx, causing a sore throat) is found to be associated with 1,238 drugs and 1,207 conditions by eHealthMe. Check the latest studies of Pharyngitis.

On Apr, 09, 2026

11,499 people reported to have side effects when taking Dapsone.
Among them, 15 people (0.13%) have Pharyngitis.

Among these 15 people:

What is the gender of people who have Pharyngitis when taking Dapsone? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Pharyngitis when taking Dapsone? *

What are other drugs people take besides Dapsone? *

Zyrtec: 3 people, 20.00%
Eluryng: 3 people, 20.00%
Nac: 3 people, 20.00%
Montelukast Sodium: 3 people, 20.00%
Zofran: 3 people, 20.00%
Methylprednisolone: 3 people, 20.00%
Lidocaine: 3 people, 20.00%
Lecithin: 3 people, 20.00%
Ketoprofen: 3 people, 20.00%
Hydroxyzine Hydrochloride: 3 people, 20.00%

What are other side effects people have besides Pharyngitis? *

Fever: 9 people, 60.00%
Dizziness: 7 people, 46.67%
Upper Respiratory Tract Infection: 5 people, 33.33%
Asthma: 5 people, 33.33%
Nausea (feeling of having an urge to vomit): 5 people, 33.33%
Dyspnea (difficult or laboured breathing): 4 people, 26.67%
Cough: 4 people, 26.67%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 26.67%
Thrombocytopenia (decrease of platelets in blood): 4 people, 26.67%
Rashes (redness): 4 people, 26.67%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 3 people, 20.00%
Immune System Disorder: 3 people, 20.00%
B-Lymphocyte Abnormalities (abnormal population of b lymphocytes in the blood, bone marrow, or tissues): 3 people, 20.00%
Asthma: 3 people, 20.00%
Multiple Myeloma (cancer of the plasma cells): 2 people, 13.33%
Hiv Infection: 2 people, 13.33%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Dapsone and have Pharyngitis?

- Check whether Pharyngitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dapsone:

Dapsone (11,732 reports)

Pharyngitis treatments and more:

Pharyngitis (21,038 reports)

Browse all side effects of Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pharyngitis:

Pharyngitis (1,238 drugs)

Browse all the conditions that are associated with Pharyngitis:

Pharyngitis (1,207 conditions)

Related publications that referenced our studies

Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on dapsone (the active ingredients of Dapsone) and Dapsone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.